Steven Cohen's MBX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 680,609 shares of MBX Biosciences, Inc. (MBX) worth $21.47 M, representing 0.02% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Steven Cohen has maintained this position in MBX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 863,305 shares. Largest reduction occurred in Q3 2025, reducing 346,120 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's MBX Biosciences (MBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly MBX Biosciences (MBX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +52,942 | Add 8.43% | 680,609 | $31.54 |
| Q3 2025 | -346,120 | Reduce 35.54% | 627,667 | $17.50 |
| Q2 2025 | +863,305 | Add 781.40% | 973,787 | $11.41 |
| Q1 2025 | +110,482 | New Buy | 110,482 | $7.38 |
| Q4 2024 | -15,600 | Sold Out | 0 | $0.00 |
| Q3 2024 | +15,600 | New Buy | 15,600 | $25.98 |
Steven Cohen's MBX Biosciences Investment FAQs
Steven Cohen first purchased MBX Biosciences, Inc. (MBX) in Q3 2024, acquiring 15,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held MBX Biosciences, Inc. (MBX) for 6 quarters since Q3 2024.
Steven Cohen's largest addition to MBX Biosciences, Inc. (MBX) was in Q2 2025, adding 973,787 shares worth $11.11 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 680,609 shares of MBX Biosciences, Inc. (MBX), valued at approximately $21.47 M.
As of the Q4 2025 filing, MBX Biosciences, Inc. (MBX) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in MBX Biosciences, Inc. (MBX) was 973,787 shares, as reported at the end of Q2 2025.